NS

Neeraj Sah

Active Director Director DIN 09564875
DIN 09564875 First appointment Apr 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value •••• Premium profile

About Neeraj Sah

Data last updated:

Neeraj Sah is a Director at Madind Pharma Private Limited (since 2022). The company operates in Chemicals. Madind Pharma Private Limited reported revenue of ₹12.2 Lakh (FY 2024).

DIN 09564875
Primary Designation Director
Industry Chemicals
First Appointment 07 Apr 2022
Oldest Company Age 4 yrs
Largest company Madind Pharma Private Limited · ₹12.2 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Madind Pharma Private Limited U24290BR2022PTC057345
Director07 Apr 20222022₹12.2 Lakh (FY 2024)Active

Board colleagues of Neeraj Sah

NameDINCompanyDesignation
Smita Kumari09564877Madind Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Madind Pharma Private Limited
Premium access

Shareholding and investment profile for Neeraj Sah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neeraj Sah

Neeraj Sah currently holds 1 directorship: Madind Pharma Private Limited (Director, since 07 Apr 2022, revenue ₹12.2 Lakh (FY 2024)).

Neeraj Sah was first appointed on 07 Apr 2022 as Director at Madind Pharma Private Limited.

The current boards of Neeraj Sah's companies include Smita Kumari (Madind Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available